0 Day
STUDY TITLE | |
---|---|
Submitted under umbrella | |
Date submitted |
- |
End date |
There is no pre-specified end date and sub-studies remain open long-term. |
Language |
English |
Efforia AI IRB approval recommendation | |
Recruitment page preview | |
Author edit | |
Informed consent |
|
Study author |
|
Principal investigator |
Matthew Amsden |
Sub-Investigator for Adverse Events |
Dr. Viral Patel |
Description |
|
Participant engagement length |
0 Days |
Sponsor |
This study is made possible by your payment to cover all supplies and expenses required to participate. |
Cost to participant |
$0 |
Included products & services | |
Outcome measures | |
Methodology |
Single Arm longitudinal where participants act as their own control |
Basic or advanced dissemination plan |
Basic |
Deviation from recruitment approach |
No |
Deviation from statistical approach |
No |
Will study include “more about you questions” |
Yes |
Recruitment jurisdictions |
United States, United Kingdom |
Clinicaltrials.Gov |
Yes |
Committment to list findings on clinicaltrials.Gov |
Yes |
This document is prepared with the assistance of AI, but is reviewed by a human.
Rational & Study Design
The Intervention
Included Products & Services
Study Design & Methodology
Inappropriate Participants & Inclusion/Exclusion
Study Design & Experience
Statistical Analysis Plan
Limitations & Justification
Human Subjects Ethics
Suitability Under Minimal Risk Umbrella Protocol
Suitability for Pay to Participate Model
Human Subjects Protection Questionnaire
Logging
Logging
Date | Event | Message | Name |
---|---|---|---|
Dec 26, 2024 21:56:28 | modified | mike | |
Dec 26, 2024 21:45:27 | modified | mike | |
Dec 26, 2024 21:43:28 | modified | mike | |
Dec 26, 2024 21:38:56 | modified | mike | |
Dec 26, 2024 21:38:50 | modified | mike | |
Dec 26, 2024 21:38:41 | modified | mike | |
Dec 26, 2024 21:36:58 | modified | mike | |
Dec 26, 2024 21:36:49 | modified | mike | |
Dec 26, 2024 21:36:41 | modified | mike | |
Dec 26, 2024 21:34:20 | modified | mike |